The judges seemed skeptical of the Trump administration's arguments that Congress implicitly gave HHS authority to require list price disclosure to ensure the "efficient administration" of Medicaid and Medicare. In other pharmaceutical news: drugmakers are testing new ways to pay for pricey treatments, the high cost of medicine is making patients forgo care, and more.

Cory Wiegert has been chosen as the new CEO of CancerLinQ. As CEO, he is tasked with developing new solutions to help oncology practices improve the day-to-day care they provide their patients and continuing to serve CancerLinQ collaborators

According to Tosh Butt, vice president of respiratory at AstraZeneca, the goal of the AstraZeneca-Geisinger collaboration is to arm patients and physicians with digital tools with the intention of speeding diagnosis and treatment decisions.